PGEN:NASDAQ
Precigen Inc
US$ ७.३६
arrow_downward
-१.६७%(-०.१२) 1D
US$ ७.३०
arrow_downward
-०.७५% (-०.०५५)bedtimeAfter hours
Closed: अक्टोबर १४, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
US$ ७.४८
High
US$ ७.७०
Low
US$ ७.३३
Mkt. cap
२.६३ अरब
Avg. vol.
४६.७८ लाख
Volume
६६.००
52-wk high
US$ ८.९८
52-wk low
US$ ३.०४
EPS
-US$ १.१०
Beta
०.९२
Shares outstanding
३५.८० करोड
No. of employees
१६०
Open
US$ ७.४८
High
US$ ७.७०
Low
US$ ७.३३
Mkt. cap
२.६३ अरब
Avg. vol.
४६.७८ लाख
Volume
६६.००
52-wk high
US$ ८.९८
52-wk low
US$ ३.०४
EPS
-US$ १.१०
Beta
०.९२
Shares outstanding
३५.८० करोड
No. of employees
१६०
News stories
From web sources and news partners
Yahoo Finance
·
२ दिन पहिले
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc